Patents by Inventor Andre R. Miserez

Andre R. Miserez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA polymorphisms in sterol-regulator-element binding proteins
    Patent number: 7960108
    Abstract: The invention relates to DNA polymorphisms in sterol regulator element binding proteins (SREBP) that are characteristic of a higher risk of genetic diseases in humans such as hyperchlolesterolemia. The corresponding polymorphisms, especially the polymorphisms on SREBP-1 and SREBP-2 are frequently observed in Alzheimer patients (SREBP-2). They are also characterized by a specific behavior in the therapy of HIV patients with proteas inhibitors and appear to have an influence on the mortality.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: June 14, 2011
    Inventor: Andre R. Miserez
  • DNA polymorphisms in sterol-regulator-element binding proteins
    Publication number: 20080261214
    Abstract: The invention relates to DNA polymorphisms in sterol regulator element binding proteins (SREBP) that are characteristic of a higher risk of genetic diseases in humans such as hyperchlolesterolemia. The corresponding polymorphisms, especially the polymorphisms on SREBP-1 and SREBP-2 are frequently observed in Alzheimer patients (SREBP-2). They are also characterized by a specific behavior in the therapy of HIV patients with proteas inhibitors and appear to have an influence on the mortality.
    Type: Application
    Filed: April 17, 2007
    Publication date: October 23, 2008
    Inventor: Andre R. Miserez
  • DNA polymorphisms in sterol regulator element binding proteins
    Patent number: 7220846
    Abstract: The invention relates to DNA polymorphisms in sterol regulator element binding proteins (SREBP) that are characteristic of a higher risk of genetic diseases in humans such as hyperchlolesterolemia. The corresponding polymorphisms, especially the polymorphisms on SREBP-1 and SREBP-2 are frequently observed in Alzheimer patients (SREBP-2). They are also characterized by a specific behavior in the therapy of HIV patients with proteas inhibitors and appear to have an influence on the mortality.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: May 22, 2007
    Inventor: Andre R. Miserez